← Back to All Filings

ISRG Exec Sells $58.8K in Stock via Pre-Arranged Trading Plan

Low SignificanceNovember 12, 2025 at 2:33:51 PM EST

INTUITIVE SURGICAL INC

$ISRG4CIK: 0001035267

Subscribe to track ISRG

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

ISRG Exec Sells $58.8K in Stock via Pre-Arranged Trading Plan

Company: INTUITIVE SURGICAL INC (ISRG) Form: 4 | Filed: 2025-11-12 Significance: Low

Insider: Curet Myriam Title: EVP & Chief Medical Officer | Relationship: Officer

Transaction: • Type: Sell (following option exercise) • Shares: 105 • Price: $560.00 • Value: $58,800 • Owned After: 353

Key Insight: This is a very small, pre-scheduled sale executed under a Rule 10b5-1 trading plan. The transaction value is negligible compared to ISRG's $204B market cap.

Market Context: The sale follows the exercise of stock options, a common practice for executive compensation. The amount sold is insignificant and unlikely to impact the market.

Comprehensive Analysis

SEC Filing Analysis: INTUITIVE SURGICAL INC (ISRG)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: An officer conducted a minor, pre-planned sale of shares valued at $58,800 after exercising stock options.
  • Market Impact: The transaction is immaterial and expected to have a neutral impact on the stock.

Company Information

FieldValue
CompanyINTUITIVE SURGICAL INC
Ticker SymbolISRG
CIK0001035267
IndustryOrthopedic, Prosthetic & Surgical Appliances & Supplies

Insider Information

FieldValue
NameCuret Myriam
CIK0001632901
Title/PositionEVP & Chief Medical Officer
RelationshipOfficer

Transaction Details

This filing reports an option exercise followed by an immediate sale of the acquired shares.

Sale Transaction:

FieldValue
Form Type4
Transaction Date2025-11-10
Transaction CodeS (Sale)
Security TypeCommon Stock
Shares Involved105
Price Per Share$560.00
Total Value$58,800
Shares Owned After353 (Indirectly, by Trust)
Ownership TypeDirect sale, remaining holdings are Indirect

Option Exercise Transaction:

FieldValue
Transaction CodeM (Option Exercise)
Shares Acquired105
Exercise Price$229.39
Total Cost$24,085.95

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value (Sale)$58,800
% of Market Cap<0.0001%
Shares Transacted105
% of Shares Outstanding<0.0001%
Post-Transaction Ownership353 shares (<0.0001% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a mega-cap company with a market capitalization of $204.26 billion, a transaction of $58,800 is financially insignificant.
  • Ownership Concentration: The insider's post-transaction holding of 353 shares is a negligible portion of the 358.5 million shares outstanding.
  • Transaction Significance: The sale represents an extremely small fraction of both the company's market value and total shares. It is a routine transaction with no informational value for investors.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is too small to have any market impact. It is a pre-planned sale, indicating it is not based on any new material non-public information.

Volume & Sentiment

  • Expected Volume Impact: None. The transaction size is a tiny fraction of the stock's typical daily trading volume.
  • Sentiment Indicator: Neutral. This is a routine executive compensation-related trade.

Additional Context

Transaction Notes

  • Special Circumstances: The filing explicitly states the transaction was made pursuant to a Rule 10b5-1 trading plan, which allows insiders to set up pre-arranged trading schedules. This removes the implication that the trade is based on immediate market sentiment.
Topics:#SECFiling#InsiderTrading#ISRG#IntuitiveSurgical#Form4#InsiderSell#StockMarket#10b51

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.